Exploring the use of genetic testing to improve pain management
Understanding barriers and facilitators to pharmacogenomic testing in chronic pain care
This study is looking at how genetic testing can help doctors choose safer and more effective pain medications for people with chronic pain, while also finding out what stops doctors from using this testing more often.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10865760 on NIH RePORTER |
What this research studies
This research investigates how genetic testing can enhance the safety and effectiveness of pain medications by identifying individual risks for adverse drug reactions. It aims to understand the barriers that prevent pain physicians from utilizing pharmacogenomic testing, despite its potential benefits. By employing a mixed methods approach, the study will gather insights from pain specialists about their knowledge and practices regarding genetic testing in pain management. The goal is to identify ways to improve access to this testing for patients suffering from chronic pain.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who are experiencing chronic pain and may benefit from tailored medication strategies.
Not a fit: Patients who are not experiencing chronic pain or are under 21 years old may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective pain management strategies for patients.
How similar studies have performed: Previous research has shown that pharmacogenomic testing can improve medication safety and efficacy in other medical fields, suggesting potential success in pain management as well.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Hendy, Katherine Marie — University of Michigan at Ann Arbor
- Study coordinator: Hendy, Katherine Marie
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.